Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Pharmaceutical Product Supply – Aluminum Hydroxide Gel

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of SPE2D9-26-F-8100.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

ALUMINUM HYDROXIDE GEL

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply and delivery of one unit of Aluminum Hydroxide Gel under specified NSN and NDC numbers to a DLA facility in Suffolk, VA.

Similar Contracts

Same NAICS industry code

NAICS: 325414
New
DIBBS
MEDICAL PHARMACY EMERGENCY NON NSN ORDER
Solicitation # SPE2DP-26-R-0002
Solicitation SPE2DP-26-R-0002 is a federal request for proposals issued by the Department of Defense Medical Supply Chain Pharmacy FSA to establish a firm-fixed price, indefinite-delivery, indefinite-quantity source of supply for the Influenza Virus Vaccine, Southern Hemisphere 2027 Formula. The requirement is for a Quadrivalent or Trivalent vaccine for individuals aged six months and older, delivered in .5 ML dose syringes with 10 syringes per package. The estimated annual quantity is 3,000 packages, with a minimum of 2,250 and a maximum of 4,500 packages over a twelve-month contract term. All supplies must be delivered to the Defense Distribution Center in Susquehanna, Pennsylvania, with 100 percent of quantities due by March 31, 2027. The contract mandates strict adherence to cold chain management and medical standards, requiring products to comply with USP requirements and CDC Advisory Committee on Immunization Practices guidance. Perishable items must be maintained within specific temperature ranges during transit, utilizing DLA-compatible temperature monitors and specialized packaging. Marking must follow Medical Marking Standard No. 1D and MIL-STD-129. Proposals must be submitted exclusively via the DLA Internet Bid Board System by October 14, 2026. Evaluation will be based on price and the ability to meet all solicitation terms, including the provision of FDA approval for manufacturers or a manufacturer's Letter of Commitment for dealers. Invoicing and receiving reports are to be processed electronically through the Wide Area Workflow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 12 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS